Flora Growth Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|
|
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |
(Address of principal executive offices) (ZIP Code)
Registrant’s telephone number, including area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbols | Name of each exchange on which registered | ||
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On August 14, 2024, Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the "Company"), held its 2024 Annual and Special Meeting of Shareholders (the "Annual Meeting"). The final voting results for the proposals submitted to a vote of the Company's shareholders at the Annual Meeting are as follows:
Proposal 1: Election of four directors to the Board of Directors of the Company (the "Board") to hold office until the Company's 2025 Annual Meeting of Shareholders or until their respective successors are elected or appointed:
| Broker | ||||||||
| Director | For | Against | Abstentions | Non-Votes | ||||
| Clifford Starke | 4,969,741 | 97,612 | 18,969 | 2,778,760 | ||||
| Kevin Taylor | 4,931,118 | 129,648 | 25,556 | 2,778,760 | ||||
| Edward Woo | 4,881,581 | 179,654 | 25,087 | 2,778,760 | ||||
| Brendan Cahill | 5,001,476 | 57,680 | 27,166 | 2,778,760 |
Proposal 2: Reappointment of Davidson & Company LLP, an independent registered public accounting firm, as auditors of the Company for the fiscal year ending December 31, 2024 and authorization of the Board to fix their renumeration.
| For | Against | Abstentions | ||
| 7,499,363 | 323,623 | 42,096 |
Proposal 3: Approval of an amendment to the Company's 2022 Incentive Compensation Plan to increase the number of shares issuable thereunder from 950,000 to 2,500,000 shares.
| Broker | ||||||
| For | Against | Abstentions | Non-Votes | |||
| 4,776,425 | 285,446 | 24,451 | 2,778,760 |
Proposal 4: Approval of the grant of stock appreciation rights of the Company to the Company's Chief Executive Officer and Chief Financial Officer.
| Broker | ||||||
| For | Against | Abstentions | Non-Votes | |||
| 4,802,189 | 253,288 | 30,845 | 2,778,760 |
Proposal 5: Approval of the issuance of 635,363 shares in accordance with Nasdaq Listing Rule 5635(a) to acquire the minority interest of TruHC Pharma GmbH.
| Broker | ||||||
| For | Against | Abstentions | Non-Votes | |||
| 4,249,883 | 184,837 | 26,704 | 2,778,760 |
No other matters were considered or voted upon at the Annual Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| FLORA GROWTH CORP. | ||
| Dated: August 14, 2024 | By: | /s/ Clifford Starke |
| Name: Clifford Starke Title: Chief Executive Officer |
||